CVS Health Corporation $CVS Shares Sold by Jupiter Asset Management Ltd.

Jupiter Asset Management Ltd. trimmed its stake in shares of CVS Health Corporation (NYSE:CVS) by 64.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 260,847 shares of the pharmacy operator’s stock after selling 477,571 shares during the period. Jupiter Asset Management Ltd.’s holdings in CVS Health were worth $20,701,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. EagleClaw Capital Managment LLC acquired a new stake in shares of CVS Health during the 4th quarter valued at approximately $229,000. Intech Investment Management LLC increased its stake in shares of CVS Health by 53.8% during the 4th quarter. Intech Investment Management LLC now owns 133,146 shares of the pharmacy operator’s stock worth $10,566,000 after purchasing an additional 46,582 shares in the last quarter. Foundations Investment Advisors LLC increased its stake in shares of CVS Health by 117.0% during the 4th quarter. Foundations Investment Advisors LLC now owns 40,085 shares of the pharmacy operator’s stock worth $3,181,000 after purchasing an additional 21,612 shares in the last quarter. Baker Avenue Asset Management LP increased its stake in shares of CVS Health by 5.9% during the 4th quarter. Baker Avenue Asset Management LP now owns 6,275 shares of the pharmacy operator’s stock worth $498,000 after purchasing an additional 351 shares in the last quarter. Finally, Godfrey Financial Associates Inc. purchased a new position in shares of CVS Health during the 4th quarter worth approximately $38,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health News Summary

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS Caremark said it will restore coverage of Eli Lilly’s Zepbound and add Lilly’s new obesity pill to its standard drug plans, a move that could boost CVS’s pharmacy-benefit relevance and improve customer access to GLP-1 medications. CVS brings back coverage for Lilly’s obesity drug Zepbound
• Positive Sentiment: The company announced expanded GLP-1 coverage options, which management framed as improving affordability and access while supporting more sustainable long-term coverage. CVS Caremark Delivers Affordability and Access to GLP-1 Weight Management Medications with Expanded Coverage Options
• Positive Sentiment: CVS Health expanded its collaboration with Salesforce to streamline call center interactions using AI, which could improve service quality and operating efficiency across its member and provider base. CVS Health to Deliver Faster, More Personalized Call Center Care for Millions of Members with Salesforce’s Agentforce Health
• Positive Sentiment: CVS Health also launched Aetna Mental Health On Demand and continued building out digital health capabilities, reinforcing its integrated care strategy. CVS Health Expands Integrated Care With Virtual Mental Health AI And GLP 1
• Neutral Sentiment: CVS received a Newsweek AI Impact Award for prescription-interpretation technology, highlighting innovation in pharmacy workflow and medication safety. CVS Health recognized for technology that improves medication safety and patient care
• Neutral Sentiment: Glenview Capital said CVS remains one of its top holdings, which supports investor confidence but does not by itself change fundamentals. Glenview Capital Keeps CVS Health (CVS) Among Top Holdings

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on CVS. Leerink Partners reissued an “outperform” rating and set a $98.00 price objective on shares of CVS Health in a research note on Thursday, March 5th. Sanford C. Bernstein raised their price objective on shares of CVS Health from $94.00 to $106.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 12th. Mizuho raised their price objective on shares of CVS Health from $102.00 to $110.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 20th. UBS Group raised their price objective on shares of CVS Health from $97.00 to $100.00 and gave the stock a “buy” rating in a research note on Thursday, May 7th. Finally, JPMorgan Chase & Co. raised their price objective on shares of CVS Health from $101.00 to $111.00 and gave the stock an “overweight” rating in a research note on Tuesday, May 12th. Twenty-two investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $98.88.

CVS Health Stock Down 2.2%

CVS stock opened at $90.97 on Friday. The stock has a market capitalization of $116.06 billion, a P/E ratio of 40.07, a PEG ratio of 0.91 and a beta of 0.60. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.66 and a current ratio of 0.87. CVS Health Corporation has a one year low of $58.50 and a one year high of $98.43. The company has a 50 day moving average price of $82.07 and a two-hundred day moving average price of $79.55.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, May 6th. The pharmacy operator reported $2.57 EPS for the quarter, topping the consensus estimate of $2.21 by $0.36. The firm had revenue of $100.43 billion during the quarter, compared to analysts’ expectations of $94.99 billion. CVS Health had a net margin of 0.72% and a return on equity of 11.88%. CVS Health’s revenue for the quarter was up 6.2% on a year-over-year basis. During the same period in the previous year, the company earned $2.25 EPS. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. As a group, sell-side analysts expect that CVS Health Corporation will post 7.44 EPS for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, May 4th. Shareholders of record on Thursday, April 23rd were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 2.9%. The ex-dividend date of this dividend was Thursday, April 23rd. CVS Health’s payout ratio is presently 117.18%.

Insider Activity at CVS Health

In other news, Director Larry Robbins sold 370,462 shares of the business’s stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $93.45, for a total transaction of $34,619,673.90. Following the completion of the sale, the director directly owned 4,824,799 shares of the company’s stock, valued at $450,877,466.55. The trade was a 7.13% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Tilak Mandadi sold 69,551 shares of the business’s stock in a transaction on Friday, May 8th. The shares were sold at an average price of $89.58, for a total transaction of $6,230,378.58. Following the sale, the executive vice president directly owned 10,133 shares of the company’s stock, valued at $907,714.14. This represents a 87.28% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 3,441,551 shares of company stock valued at $323,703,977 over the last ninety days. 0.85% of the stock is owned by corporate insiders.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.